H.R. 1427 - Promoting Innovation and Access to Life-Saving Medicine Act
- Sponsor:
- Henry A. Waxman
- Summary:
- To amend the Public Health Service Act to provide for the licensing of biosimilar and biogeneric biological products, and for other purposes. (by CRS)
- Status:
- The bill has been introduced.
Promoting Innovation and Access to Life-Saving Medicine Act
H.R. 1427 — 111th Congress (2009–2010)
- Keywords
- Biosimilars, Biotechnology, Generics
- Summary
- To amend the Public Health Service Act to provide for the licensing of biosimilar and biogeneric biological products, and for other purposes. (by CRS)
- Learn More
- At OpenCongress
- Title
- To amend the Public Health Service Act to provide for the licensing of biosimilar and biogeneric biological products, and for other purposes.
- Other Titles
- Promoting Innovation and Access to Life-Saving Medicine Act
- Sponsor
- Henry A. Waxman
- Co-Sponsors
- Subjects
- Health
- Administrative remedies
- Child health
- Civil actions and liability
- Department of Health and Human Services
- Drug safety, medical device, and laboratory regulation
- Intellectual property
- Judicial procedure and administration
- Licensing and registrations
- Medical research
- Related Bills
- Major Actions
Introduced 3/11/2009 Referred to Committee - Bill History
-
There have been no votes on this bill.
Action Date Description Introduced 3/11/2009 3/11/2009 Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. 3/11/2009 Referred to House Energy and Commerce 3/11/2009 Referred to House Judiciary 3/12/2009 Referred to the Subcommittee on Health. Number Sponsor Date Offered Status
Total contributions given to House members from interest groups that…
supported this bill
opposed this bill
Contributions data source: OpenSecrets.org